Study of Microbicide Gel Shows Reduced Risk of HIV & Herpes Infections in Women
Wednesday, July 21st, 2010FHI contributed to a clinical trial in South Africa of a vaginal gel that has been shown to be 39% effective in reducing women’s risk of HIV infection and 51% effective in preventing new infections.
